Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enhancer hijacking at the ARHGAP36 locus is associated with connective tissue to bone transformation. | Nat Commun | 2023 | 37041138 | PubTator, text mining | PubMed |
| Optimization of Cas9 activity through the addition of cytosine extensions to single-guide RNAs. | Nat Biomed Eng | 2023 | 37037965 | PubTator, text mining | PubMed |
| Emerging biologics for the treatment of pulmonary arterial hypertension. | J Drug Target | 2023 | 37026714 | PubTator, text mining | PubMed |
| Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies. | Cancer Med | 2023 | 37021939 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities. | Cancer Discov | 2023 | 37011011 | PubTator, text mining | PubMed |
| Osteochondrogenesis by TGF-β3, BMP-2 and noggin growth factor combinations in an ex vivo muscle tissue model: Temporal function changes affecting tissue morphogenesis. | Front Bioeng Biotechnol | 2023 | 37008034 | PubTator, text mining | PubMed |
| Considerations for modelling diffuse high-grade gliomas and developing clinically relevant therapies. | Cancer Metastasis Rev | 2023 | 37004686 | PubTator, text mining | PubMed |
| Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis. | Breast Cancer Res Treat | 2023 | 37002487 | PubTator, text mining | PubMed |
| Editorial: Current progress in mesenchymal stem/stromal cell research, volume II. | Front Cell Dev Biol | 2023 | 36994102 | PubTator, text mining | PubMed |
| Machine learning-based predictive models and drug prediction for schizophrenia in multiple programmed cell death patterns. | Front Mol Neurosci | 2023 | 36993785 | PubTator, text mining | PubMed |
| Assessment of the Mutation Profile of Tonsillar Squamous Cell Carcinomas Using Targeted Next-Generation Sequencing. | Biomedicines | 2023 | 36979829 | PubTator, text mining | PubMed |
| Somatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges. | Brain Sci | 2023 | 36979334 | PubTator, text mining | PubMed |
| Neuraminidase 1 promotes renal fibrosis development in male mice. | Nat Commun | 2023 | 36973294 | PubTator, text mining | PubMed |
| Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders. | Front Genet | 2023 | 36959829 | PubTator, text mining | PubMed |
| The promise of metabolic imaging in diffuse midline glioma. | Neoplasia | 2023 | 36944297 | PubTator, text mining | PubMed |
| Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as "CNS embryonal tumor with BRD4-LEUTX fusion". | Acta Neuropathol Commun | 2023 | 36934287 | PubTator, text mining | PubMed |
| Discovery of Orally Bioavailable FGFR2/FGFR3 Dual Inhibitors via Structure-Guided Scaffold Repurposing Approach. | ACS Med Chem Lett | 2023 | 36923909 | PubTator, text mining | PubMed |
| Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors. | World J Pediatr | 2023 | 36914906 | PubTator, text mining | PubMed |
| Sporadic spinal psammomatous malignant melanotic nerve sheath tumor: A case report and literature review. | Front Oncol | 2023 | 36910634 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=19